Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma

Overview of attention for article published in Journal of Hematology & Oncology, January 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 176 Dimensions

Readers on

mendeley: 138 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 11,591 followers.

Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma. https://t.co/xFHMDwfxIu

06 Dec 2017

Reply Repost Favourite

RT @sesiegler: Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells i... https://t.co/eiYwHJ…

23 Jul 2017

Reply Repost Favourite

RT @sesiegler: Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells i... https://t.co/eiYwHJ…

23 Jul 2017

Reply Repost Favourite

RT @sesiegler: Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells i... https://t.co/eiYwHJ…

22 Jul 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.